Dilja Krueger, Ph.D.
Affiliations: | 2007 | Yale University, New Haven, CT |
Area:
Neuroscience BiologyGoogle:
"Dilja Krueger"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Angus C. Nairn | grad student | 2007 | Yale | |
| (Molecular mechanisms of persistent cocaine-induced alterations in corticostriatal function.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| El-Kordi A, Winkler D, Hammerschmidt K, et al. (2013) Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism. Behavioural Brain Research. 251: 41-9 |
| Krueger DD, Osterweil EK, Chen SP, et al. (2011) Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome. Proceedings of the National Academy of Sciences of the United States of America. 108: 2587-92 |
| Krueger DD, Howell JL, Oo H, et al. (2009) Prior chronic cocaine exposure in mice induces persistent alterations in cognitive function. Behavioural Pharmacology. 20: 695-704 |
| Krueger DD, Nairn AC. (2007) Expression of PKC substrate proteins, GAP-43 and neurogranin, is downregulated by cAMP signaling and alterations in synaptic activity. The European Journal of Neuroscience. 26: 3043-53 |
| Olausson P, Jentsch JD, Krueger DD, et al. (2007) Orbitofrontal cortex and cognitive-motivational impairments in psychostimulant addiction: evidence from experiments in the non-human primate. Annals of the New York Academy of Sciences. 1121: 610-38 |
| Andrade EC, Krueger DD, Nairn AC. (2007) Recent advances in neuroproteomics. Current Opinion in Molecular Therapeutics. 9: 270-81 |
| Krueger DD, Howell JL, Hebert BF, et al. (2006) Assessment of cognitive function in the heterozygous reeler mouse. Psychopharmacology. 189: 95-104 |